#fiercepharma
LightNews LightNews
mercybenz.bsky.social
FiercePharma 06-02-2025
June 2, 2025 at 4:39 PM
lovekat41.bsky.social
kffhealthnews.org/morning-brea...
HHS Spends $290 Million On Extra Radiation Sickness Medication - KFF Health News
It could be a "troubling sign of the times," FiercePharma says, noting the money is buying an "undisclosed" amount of the Amgen drug Nplate — approved to treat blood cell injuries from acute radiation...
kffhealthnews.org
April 2, 2026 at 7:17 PM
drtimos.bsky.social
Thoughts on this? >> Bharat Biotech enters cell and gene therapy market with $75M
production investment: reports - FiercePharma >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #healthcare #pharma #competitivemarketing
Bharat Biotech enters cell and gene therapy market with $75M production investment: reports - FiercePharma
Bharat Biotech enters cell and gene therapy market with $75M production investment: reports  FiercePharma
dlvr.it
March 25, 2025 at 7:01 AM
drtimos.bsky.social
Thoughts on this? >> Bluebird bio receives rival M&A bid worth 50% higher
than Carlyle-SK offer - FiercePharma >> Comment below! #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #healthcare #competitivemarketing #biotech
Bluebird bio receives rival M&A bid worth 50% higher than Carlyle-SK offer - FiercePharma
Bluebird bio receives rival M&A bid worth 50% higher than Carlyle-SK offer  FiercePharma
dlvr.it
March 29, 2025 at 1:00 AM
sketchynews.net
[FiercePharma]AstraZeneca, Sanofi, Lilly, Pfizer CEOs meet with Xi Jinping amid US-China trade tensions - FiercePharma As U.S. President Donald Trump threatens a new round of tariffs as part of an onshoring push, Chinese President Xi Jinping is courting foreign investment as well, including from...
March 30, 2025 at 5:30 PM
drtimos.bsky.social
Thoughts on this? >> Fierce Pharma Asia—Takeda R&D chief's new strategy;
AZ, Daiichi's ADC nod; Fosun's failed Henlius buy -
FiercePharma: Fierce Pharma Asia—Takeda R&D… >> Comment below! #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #pharma #competitivemarketing #healthcare
Fierce Pharma Asia—Takeda R&D chief's new strategy; AZ, Daiichi's ADC nod; Fosun's failed Henlius buy - FiercePharma
Fierce Pharma Asia—Takeda R&D chief's new strategy; AZ, Daiichi's ADC nod; Fosun's failed Henlius buy  FiercePharma
dlvr.it
January 25, 2025 at 7:00 PM
fluxandflow.bsky.social
Wow. I'm looking at the complications table posted by Fiercepharma, and comparing it to the number of patients treated, and I'm seeing a ~20% chance of serious cases (which sounds a lot like a Serious Adverse Event) and a 5% mortality rate being reported?

www.fda.gov/safety/repor...
December 14, 2023 at 8:51 PM
ritters90.bsky.social
I'm excited to attend the Fierce JPM Week 2025, on January 14-15! Join me and 500+ Biopharma Executives in San Francisco! Learn more here: app.ingo.me/q/h89xl

#FierceJPMWeek #WeAreFierce #FierceBiotech #FiercePharma #JPMWeek #Pharma #Biotech
January 6, 2025 at 3:24 AM
chemjobber.bsky.social
Lol Novo Nordisk got a 483 for its central semaglutide manufacturing plant back in March

via FiercePharma

www.fiercepharma.com/manufacturin...
Novo Nordisk hit with FDA write-up over production issues at critical semaglutide plant
Novo Nordisk landed in hot water with the FDA following an inspection at one of the drugmaker’s key semaglutide and insulin manufacturing plants this past spring. | The FDA issued a manufacturing-rela...
www.fiercepharma.com
October 31, 2024 at 6:51 PM
sstrumello.bsky.social
BMS plots another DTC platform, this one offering Sotyktu at 86% discount to cash-pay patients via FiercePharma www.fiercepharma.com/marketing/bm...
BMS plots another DTC platform, this one offering Sotyktu at 86% discount to cash-pay patients
On the heels of the launch of an online direct-to-patient (DTP) program offering | On the heels of the launch of an online direct-to-patient program offering discounted Eliquis to certain U.S. patient...
www.fiercepharma.com
September 27, 2025 at 1:01 PM
hugobalm.bsky.social
50 new drug products were approved in 2024 by the @fda.gov Bringing further innovation to patient needs #fiercepharma
www.fiercepharma.com/pharma/2024-...
2024 drug approvals: Small companies loom large with several key FDA nods
Comparing the FDA new drug approval lists from 2023 and 2024 reveals a significant difference in the size of the companies that achieved the regulatory triumphs. | Each year, many scientists and other...
www.fiercepharma.com
January 7, 2025 at 9:49 AM
gregfolkers.bsky.social
FiercePharma: Fierce 50 of 2026

bit.ly/4co6iVc
September 2, 2026 at 7:02 PM
lytir.bsky.social
📰 News Snapshot (24h) · 🟢 Fiercepharma: CSL shares up 17% as immunoglobulin boost points to signs of recovery… #investing #stocks #StockMarket
August 18, 2026 at 3:58 PM
sstrumello.bsky.social
After FDA sign-off, Colorado's drug import plan faces tough road ahead via FiercePharma www.fiercepharma.com/pharma/after...
After FDA sign-off, Colorado's drug import plan faces tough road ahead
Amid multiple efforts to rein in steep drug costs in the U.S., Colorado has received the all-clear to take matters into its own hands, albeit through a framework that may be difficult to pull off i | ...
www.fiercepharma.com
June 19, 2026 at 2:19 AM
sstrumello.bsky.social
The brief reign of Novo Nordisk’s Wegovy pill as the lone oral GLP-1 approved for obesity has ended as Eli Lilly’s orforglipron cruised past an FDA green light Wednesday. via FiercePharma www.fiercepharma.com/pharma/lilly...
Lilly answers Novo's GLP-1 pill with highly anticipated FDA nod for Foundayo
The brief reign of Novo Nordisk’s Wegovy pill as the lone oral GLP-1 approved for obesity has ended as Eli Lilly’s orforglipron cruised past an FDA green light Wednesday.  | The FDA has approved Lilly...
www.fiercepharma.com
April 2, 2026 at 2:08 AM
sstrumello.bsky.social
Novo Nordisk's US headquarters in Plainsboro, New Jersey under fire in latest FDA warning letter via FiercePharma www.fiercepharma.com/pharma/novo-...
Novo Nordisk's US headquarters under fire in latest FDA warning letter
Amid the company’s efforts to resolve issues raised during an FDA inspection early last year, Novo Nordisk’s operating base in Plainsboro, New Jersey—already the recipient of a recent Form 483—has | A...
www.fiercepharma.com
March 14, 2026 at 1:23 AM
sstrumello.bsky.social
FOIA lawsuit targets Trump MFN pricing deals with Lilly, Pfizer via FiercePharma www.fiercepharma.com/pharma/publi...
Advocacy group files FOIA lawsuit to gain further clarity on Trump administration's MFN pricing deals
Consumer advocacy organization Public Citizen has filed (PDF) a Freedom of Information Act (FOIA)
www.fiercepharma.com
February 15, 2026 at 3:35 PM
sstrumello.bsky.social
FDA has issued its worst-ever rating to Novo Nordisk's Indiana plant: Official Action Indicated (OAI) due to issues such as “particulate contamination”. via FiercePharma www.fiercepharma.com/manufacturin...
Novo plant hit with FDA's most serious inspection classification, portending possible delays for partners
It appears problems at Novo Nordisk’s recently acquired manufacturing facility in Indiana aren’t going to be solved any time soon. | The FDA has tagged Novo Nordisk's newly acquired manufacturing faci...
www.fiercepharma.com
October 18, 2025 at 12:42 PM
sstrumello.bsky.social
Novo Nordisk, under new CEO Doustdar, freezes hiring in non-critical business areas via FiercePharma www.fiercepharma.com/pharma/novo-...
Novo Nordisk, under new CEO Doustdar, freezes hiring in non-critical business areas
As Novo Nordisk transitions from the leadership of longtime CEO Lars Fruergaard Jørgensen to newly appointed chief Maziar Mike Doustdar, the company isn't making a point to rapidly add staffers.
www.fiercepharma.com
August 21, 2025 at 12:31 AM
sstrumello.bsky.social
Sanofi opens doors to $130M 'flagship' US office facility in New Jersey via FiercePharma www.fiercepharma.com/pharma/sanof...
Sanofi opens doors to $130M 'flagship' US office facility in New Jersey
In the wake of the COVID-19 pandemic, which acclimated many workers to at-home or hybrid work models, French drugmaker Sanofi concluded that the traditional office paradigm was on its way out. | Sanof...
www.fiercepharma.com
May 25, 2025 at 1:24 PM
sstrumello.bsky.social
Sandoz takes Amgen to court again, challenging its patents on decades-old Enbrel via FiercePharma www.fiercepharma.com/pharma/sando...
Sandoz takes Amgen to court again, challenging its patents on decades-old Enbrel
Originally approved by the FDA in 1998, Amgen’s Enbrel is still sailing along without facing biosimilar competition in the United States. | Sandoz has filed an antitrust lawsuit in federal court in Vi...
www.fiercepharma.com
April 14, 2025 at 4:46 PM
sstrumello.bsky.social
Eli Lilly, Novo Nordisk lead revenue boom in the 'always tricky' Q4 via FiercePharma www.fiercepharma.com/pharma/eli-l...
Eli Lilly, Novo Nordisk lead revenue boom in the 'always tricky' Q4
Revenues in the biopharma industry continued to boom in the fourth quarter of last year, following a pattern seen increasingly throughout 2024. | Revenues in the biopharma industry continued to boom i...
www.fiercepharma.com
February 24, 2025 at 6:31 PM
medliveofficial.bsky.social
📣 Your #HCPEducation campaign is launched—but will it leave a lasting impact?​

On May 20 in our #FiercePharma webinar, Medlive's Seth Gordon and industry leaders will share real-world insights on retaining #HCP engagement in an ever-evolving digital space.💡💻

🔗 Register now: bit.ly/3RIyJm9%E2%8...
May 8, 2025 at 8:12 PM
sovereignty.bsky.social
Top 20 drugs losing patent - FiercePharma.

Humira is a big one with Amjevita right behind it as a biosimilar.

Actemra/tocilizumab, aka Toci, is great as well. As an Anti-IL6 it's a great at preventing cytokine storms or a host of other inflammatory effects. #medicine #drugs #health #biotech
The top 10 drugs losing US exclusivity in 2023
When AbbVie and Amgen inked their Humira patent settlement way back in 2017, it seemed way off in the distant future that the AbbVie bestseller would finally face biosimilar competition. Now, the da...
www.fiercepharma.com
September 21, 2023 at 4:06 AM
sovereignty.bsky.social
I love Fiercepharma, as my go to source of the Pharmaceutical industry, Biotech, Medtech, Business and understanding generally how Medicine is evolving.

To that end here are the top 10 most expensive drugs: www.fiercepharma.com/special-repo...

Keep in mind gene therapies are cures, hence the $$$$
Most expensive drugs in the US in 2023
In an era of new gene therapies, a fresh roster of drugs has emerged as the priciest. Chalk it up to gene therapies’ potential as one-time, curative treatments—a factor that’s prompted drugmake...
www.fiercepharma.com
September 9, 2023 at 7:50 PM